Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus

Current Rheumatology Reports

Volumn 15, Issue 11, 2013, Pages

  Greco, Carol M ^a   Nakajima, Claire ^b   Manzi, Susan ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acupuncture; Alternativemedicine; Anti oxidants; Cognitive behavioral therapy; Complementary medicine; DHEA; Fish oil; Integrativemedicin; Interpersonal therapy; Meditation; Mind body treatments; N acetyl cysteine; Omega 3 fatty acids; Oxidative stress; Supplements; Systemic lupus erythematosus; Turmeric; Vitamin B6; Vitamin C; Vitamin D; Vitamin EV; Vitamins

Indexed keywords

VITAMIN;

ACUPUNCTURE; ALTERNATIVE MEDICINE; DIET SUPPLEMENTATION; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROCEDURES; METHODOLOGY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUPUNCTURE THERAPY; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIND-BODY THERAPIES; VITAMINS;

EID: 84893781908     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-013-0378-3     Document Type: Article

References (69)

1. Manzi S, Meilahn E, Rairie J, Conte C, Medsger T, Jansen- McWilliams L, et al. Age- specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997;145(5):408-15 (Pubitemid 27084212)
2. Ward M. Premature morbidity from cardiovascular and cerebrovascular diseases inwomen with systemic lupus erythematosus.Arthritis Rheum. 1999;42(2):338-46 (Pubitemid 29072852)
3. Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum. 2009;61(6):822-9
4. Haija AJ, Schulz SW. The role and effect of complementary and alternative medicine in systemic lupus erythematosus. Rheum Dis Clin North Am. 2011;37(1):47-62. This paper provides a review and discussion of CAM in SLE and other rheumatologic conditions
5. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;(12):1-23
6. Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5): 355-61
7. Moore AD, PetriMA, Manzi S, Isenberg DA, Gordon C, Senecal JL, et al. The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis Rheum. 2000;43(6):1410-8 (Pubitemid 30416329)
8. Leong KP, Chan SP. Why Lupus patients use alternative medicine. Lupus. 2003;12:659-64 (Pubitemid 37173661)
9. Alvarez-Nemegyei J, Bautista-Botello A. Complementary or alternative therapy use and health status in systemic lupus erythematosus. Lupus. 2009;18:159-63
10. Aghdassi E, Morrison S, Landolt-Marticorena C, Su J, Pineau CA, Gladman D, et al. The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus. J Rheumatol. 2010;37(1):87-90
11. CostenbaderKH,Kang JH, Karlson EW.Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol. 2010;172(2):205-16
12. Hiraki LT, Munger KL, Costenbader KH, Karlson EW.Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res. 2012;64(12):1829-36
13. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81
14. Kamen DL, Aranow C. The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 2008;10(4): 273-80
15. Kamen DL. Vitamin D in lupus - new kid on the block? Bull NYU Hosp Jt Dis. 2010;68(3):218-22
16. Szodoray P, Tarr T, Bazso A, Poor G, Szegedi G, Kiss E. The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary. Scand J Rheumatol. 2011;40(2):122-6
17. Ravenell RL, Kamen DL, Spence JD, Hollis BW, Fleury TJ, Janech MG, et al. Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am J Med Sci. 2012;344(4):268-73
18. Yeap SS, Othman AZ, Zain AA, Chan SP. Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int J Rheum Dis. 2012;15(1):17-24
19. Abou-Raya A, Abou-Raya S, Helmii M. The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial. J Rheumatol. 2013;40(3): 265-72. This paper describes a RCT of Vitamin D in 178 SLE patients. Twelve months of supplementation was associated with reduction in SLEDAI as well as modulation of proinflammatory and hemostatic markers
20. Aranow C, Dall'Era M, Massarotti EM, Mackay M, Coca A, Koumpouras F, et al. A double-blind randomized placebocontrolled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus. Arthritis Rheum. 2012;64(10 (supplement)):S1110
21. Minami Y, Sasaki T, Arai Y, Kurisu Y, Hisamichi S. Diet and systemic lupus erythematosus: a 4 year prospective study of Japanese patients. J Rheumatol. 003;30(4):747-54 (Pubitemid 36402768)
22. Minami Y, Hirabayashi Y, Nagata C, Ishii T, Harigae H, Sasaki T, et al. Intakes of vitamin B6 and dietary fiber and clinical course of systemic lupus erythematosus: a prospective study of Japanese female patients. J Epidemiol. 2011;21(4):246-54
23. Tam LS, Li EK, Leung VY, Griffith JF, Benzie IF, Lim PL, et al. Effects of vitamins C and E on oxidative stressmarkers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. J Rheumatol. 2005;32(2):275-82 (Pubitemid 40209125)
24. Ward M. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis. Am J Kidney Dis. 2000;36(3):516-25
25. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112(4):298-304 (Pubitemid 34219443)
26. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71(1 Suppl):343S-8S (Pubitemid 30046139)
27. Duffy EM, Meenagh GK, McMillan SA, Strain JJ, Hannigan BM, Bell AL. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol. 2004;31(8):1551-6 (Pubitemid 39006636)
28. Wright SA, O'Prey FM,McHenry MT, Leahey WJ, Devine AB, Duffy EM, et al. A randomised interventional trial of omega-3- polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis. 2008;67(6):841-8 (Pubitemid 351829386)
29. Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ, Falardeau P. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int. 1989;36(4):653-60
30. Clark WF, Parbtani A, Naylor CD, Levinton CM, Muirhead N, Spanner E, et al. Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int. 1993;44(1):75-86 (Pubitemid 23198028)
31. Walton AJ, Snaith ML, Locniskar M, Cumberland AG,MorrowWJ, IsenbergDA. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis. 1991;50(7):463-6
32. Gergely Jr P, Grossman C, Niland B, Puskas F, Neupane H, Allam F, et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002;46(1): 175-90 (Pubitemid 34121663)
33. Shah D, Aggarwal A, Bhatnagar A, Kiran R,Wanchu A. Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus. Free Radic Res. 2011;45(5):559-67
34. Tewthanom K, Janwitayanujit S, Totemchockcyakarn K, Panomvana Na Ayudhya D. The effect of high dose of N-acetylcysteine in lupus nephritis: a case report and literature review. J Clin Pharm Ther. 2010;35(4):483-5
35. Tewthanom K, Janwitayanujit S, Totemchockchyakarn K, Panomvana Na Ayudhya D. Pharmacodynamic effect of NAcetylcysteins as adjunctive therapy in mild systemic lupus erythematosus patients. Trop J Pharm Res. 2011;10(2):141-6
36. Lai Z-W, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A, et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012;64(9):2937-46. This study evaluated 3 doses of NAC and placebo in 36 SLE patients. Positive effects were found on SLEDAI scores, anti-dsDNA, and BILAG
37. Garcia RJ, Francis L, Dawood M, Lai ZW, Faraone SV, Perl A, et al. Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus. Arthritis Rheum. 2013;65(5):1313-8. In 24 SLE patients from the Lai et al. (2012) study, above, NAC was associated with self-reported improvements in cognitive function
38. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-56 (Pubitemid 40259916)
39. Bright JJ. Curcumin and autoimmune disease. Adv Exp Med Biol. 2007;595:425-51
40. Khajehdehi P, Zanjaninejad B, Aflaki E, Nazarinia M, Azad F, Malekmakan L, et al. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr. 2012;22(1):50-7
41. Chang DM, Lan JL, Lin HY, Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002;46(11):2924-7
42. Chang DM,Chu SJ,ChenHC, Kuo SY, Lai JH. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus. Ann Rheum Dis. 2004;63(12):1623-6 (Pubitemid 39573692)
43. Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2002;46(7): 1820-9 (Pubitemid 34774514)
44. Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, et al. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum. 2004;50(9):2858-68
45. van Vollenhoven RF, Park JL, Genovese MC, West JP, McGuire JL. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus. 1999;8(3):181-7 (Pubitemid 29186836)
46. Sanchez-Guerrero J, Fragoso-Loyo HE, Neuwelt CM, Wallace DJ, Ginzler EM, Sherrer YR, et al. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy. J Rheumatol. 2008;35(8):1567-75
47. Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH, et al. Effects of dehydroepiandrosterone on fatigue and wellbeing in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Ann Rheum Dis. 2010;69(6):1144-7
48. van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12months. J Rheumatol. 1998;25(2): 285-9 (Pubitemid 28088256)
49. Marder W, Somers EC, Kaplan MJ, Anderson MR, Lewis EE, McCune WJ. Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study. Lupus. 2010;19(10):1229-36
50. Vickers AJ, Cronin AM, Maschino AC, Lewith G, MacPherson H, Foster NE, et al. Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med. 2012;172(19):1444-53
51. Greco CM, Kao AH,Maksimowicz-McKinnon K, Glick RM, Houze M, Sereika SM, et al. Acupuncture for systemic lupus erythematosus: a pilot RCT feasibility and safety study. Lupus. 2008;17(12):1108-16
52. Scharf H, Mansmann U, Streitberger K, Witte S, Kramer J, Maier C, et al. Acupuncture and knee osteoarthritis. Ann Intern Med. 2006;145:12-20
53. Josefson A, Kreuter M. Acupuncture to reduce nausea during chemotherapy treatment of rheumatic diseases. Rheumatology (Oxford). 2003;42:1149-54 (Pubitemid 37258475)
54. Sundquist K, Li X, Hemminki K, Sundquist J. Subsequent risk of hospitalization for heuropsyciatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Arch Gen Psychiatry. 2008;65(5):501-7 (Pubitemid 351645045)
55. Daleboudt GM, Broadbent E, McQueen F, Kaptein AA. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res. 2011;63(3):342-50
56. Greco CM, Li T, Sattar A, Kao AH, Danchenko N, Edmundowicz D, et al. Association between depression and vascular disease in systemic lupus erythematosus. J Rheumatol. 2012;39(2):262-8
57. Zhang J, Wei W, Wang C. Effects of psychological interventions for patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus. 2012;21(10):1077-87
58. KarlsonEW, LiangMH, Eaton H, Huang J, Fitzgerald L, RogersMP, et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum. 2004;50(6):1832-41 (Pubitemid 38725096)
59. HarrisonMJ, Morris KA, Horton R, Toglia J, Barsky J, Chait S, et al. Results of intervention for lupus patients with self-perceived cognitive difficulties. Neurology. 2005;65(8):1325-7 (Pubitemid 41508241)
60. Drenkard C, Dunlop-Thomas C, Easley K, Bao G, Brady T, Lim SS. Benefits of a self- management program in low-income African- American women with systemic lupus erythematosus: results of a pilot test. Lupus. 2012;21(14):1586-93
61. Navarrete-Navarrete N, Peralta-Ramirez MI, Sabio-Sanchez JM, Coin MA, Robles- Ortega H, Hidalgo-Tenorio C, et al. Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. Psychother Psychosom. 2010;79(2):107-15
62. Greco CM, Rudy TE,Manzi S. Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. Arthritis Rheum. 2004;51(4):625-34 (Pubitemid 39056252)
63. Brown RT, Shaftman SR, Tilley BC, Anthony KK, Kral MC, Maxson B, et al. The health education for lupus study: a randomized controlled cognitive-behavioral intervention targeting psychosocial adjustment and quality of life in adolescent females with systemic lupus erythematosus. Am J Med Sci. 2012;344(4): 274-82
64. Morone NE, Greco CM,Weiner DK. Mindfulness meditation for the treatment of chronic low back pain in older adults: a randomized controlled pilot study. Pain. 2008;134(3):310-9
65. Kabat-Zinn J, Wheeler EP, Light T, Skillings A, Scharf MJ, Cropley TG, et al. Influence of a Mindfulness Meditation-Based Stress Reduction Intervention on Rates of Skin Clearing in Patients With Moderate to Severe Psoriasis Undergoing Photo Therapy (UVB) and Photochemotherapy (PUVA). Psychosom Med. 1998;60(5):625-32 (Pubitemid 28453029)
66. Rosenkranz MA, Davidson RJ, Maccoon DG, Sheridan JF, Kalin NH, LutzA. Acomparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain Behav Immun. 2013;27(1):174-84
67. Pradhan EK, Baumgarten M, Langenberg P, Handwerger B, Gilpin AK, Magyari T, et al. Effect of Mindfulness-Based Stress Reduction in rheumatoid arthritis patients. Arthritis Rheum. 2007;57(7):1134-42 (Pubitemid 47585458)
68. Rosenzweig S, Greeson JM, Reibel DK, Green JS, Jasser SA, Beasley D. Mindfulness- based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice. J Psychosom Res. 2010;68(1):29-36
69. Zautra AJ, Davis MC, Reich JW, Nicassario P, Tennen H, Finan P, et al. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol. 2008;76(3):408-21 (Pubitemid 351822341)